Journal article · 2023
Design, synthesis, and evaluation of 1H‐benzo[d]imidazole‐4‐carboxamide PARP ‐1 inhibitors using different saturated nitrogen‐contained heterocycle as linker group
Chemical Biology & Drug Design, 101(6), 1335–1347 · Published 8 February 2023 · DOI 10.1111/cbdd.14216
In brief
“Design, synthesis, and evaluation of 1H‐benzo[d]imidazole‐4‐carboxamide PARP ‐1 inhibitors using different saturated nitrogen‐contained heterocycle as linker group” is a 2023 journal article by Kaiyue Wu and 9 co-authors, published in Chemical Biology & Drug Design. OpenAlex counts 11 citations as of 19 November 2026, which puts it in the top 5% of works published in 2023 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 11
- Most cited in
- 2024 (4)
- Field-weighted impact
- 1.29
- References
- 28
- Authors
- 10
Abstract
Poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors have been successfully applied in the clinical treatment of various cancer. Side effects and drug resistant cases were reported, and more effective PARP-1 inhibitors were required. However, studies on the AD site of PARP-1 inhibitors are currently incomplete. Therefore, to synthesize more potential candidate PARP-1 inhibitors and disclose some AD… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Wu, K., Peng, X., Li, Y., Chen, M., Liu, Y., Liu, D., Jiang, L., He, Y. L., Peng, J., & Cao, X. (2023). Design, synthesis, and evaluation of 1H‐benzo[d]imidazole‐4‐carboxamide PARP ‐1 inhibitors using different saturated nitrogen‐contained heterocycle as linker group. Chemical Biology & Drug Design, 101(6), 1335–1347. https://doi.org/10.1111/cbdd.14216
MLA 9
Wu, Kaiyue, et al. “Design, synthesis, and evaluation of 1H‐benzo[d]imidazole‐4‐carboxamide PARP ‐1 inhibitors using different saturated nitrogen‐contained heterocycle as linker group.” Chemical Biology & Drug Design, vol. 101, no. 6, 2023, pp. 1335–1347. https://doi.org/10.1111/cbdd.14216.
Chicago
Wu, Kaiyue, Xiaoyu Peng, Yang Li, Miaojia Chen, Yunfan Liu, Dan Liu, Lizhi Jiang, Yan Lan He, Junmei Peng, and Xuan Cao. 2023. “Design, synthesis, and evaluation of 1H‐benzo[d]imidazole‐4‐carboxamide PARP ‐1 inhibitors using different saturated nitrogen‐contained heterocycle as linker group.” Chemical Biology & Drug Design 101 (6): 1335–1347. https://doi.org/10.1111/cbdd.14216.
Harvard
Wu, K. et al. (2023) ‘Design, synthesis, and evaluation of 1H‐benzo[d]imidazole‐4‐carboxamide PARP ‐1 inhibitors using different saturated nitrogen‐contained heterocycle as linker group’, Chemical Biology & Drug Design, 101(6), pp. 1335–1347. doi:10.1111/cbdd.14216.
IEEE
K. Wu et al., “Design, synthesis, and evaluation of 1H‐benzo[d]imidazole‐4‐carboxamide PARP ‐1 inhibitors using different saturated nitrogen‐contained heterocycle as linker group,” Chemical Biology & Drug Design, vol. 101, no. 6, pp. 1335–1347, 2023, doi: 10.1111/cbdd.14216.
BibTeX
@article{wu2023design,
title = {{Design, synthesis, and evaluation of 1H‐benzo[d]imidazole‐4‐carboxamide PARP ‐1 inhibitors using different saturated nitrogen‐contained heterocycle as linker group}},
author = {Wu, Kaiyue and Peng, Xiaoyu and Li, Yang and Chen, Miaojia and Liu, Yunfan and Liu, Dan and Jiang, Lizhi and He, Yan Lan and Peng, Junmei and Cao, Xuan},
journal = {Chemical Biology \& Drug Design},
year = {2023},
volume = {101},
number = {6},
pages = {1335--1347},
doi = {10.1111/cbdd.14216},
url = {https://doi.org/10.1111/cbdd.14216}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 4 | |
| 2025 | 3 | |
| 2026 | 4 |
Its field-weighted citation impact is 1.29: it has been cited 1.29 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- PARP-1 inhibitors
- linkers
- structure-activity relationship
- MDA-MB-436 cells
- antiproliferative activity
- 1,4-diazepane
- piperazine
- 3-methylfuran
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Wu, K., Peng, X., Li, Y., Chen, M., Liu, Y., Liu, D., Jiang, L., He, Y. L., Peng, J., & Cao, X. (2023). Design, synthesis, and evaluation of 1H‐benzo[d]imidazole‐4‐carboxamide PARP ‐1 inhibitors using different saturated nitrogen‐contained heterocycle as linker group. Chemical Biology & Drug Design, 101(6), 1335–1347. https://doi.org/10.1111/cbdd.14216
How many times has this paper been cited?
11 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Kaiyue Wu, Xiaoyu Peng, Yang Li, Miaojia Chen, Yunfan Liu, Dan Liu, Lizhi Jiang, Yan Lan He, Junmei Peng, Xuan Cao.
What is the DOI of this paper?
10.1111/cbdd.14216, permanently at https://doi.org/10.1111/cbdd.14216. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.